Institut de radioprotection et de sûreté nucléaire

Advancing Precision Care: GE HealthCare Introduces an Innovative Solution to Help Expand Interventional CT Access

Retrieved on: 
Tuesday, April 18, 2023

Interventional radiology – and specifically interventional CT – plays a key role in the diagnosis and treatment of disease.

Key Points: 
  • Interventional radiology – and specifically interventional CT – plays a key role in the diagnosis and treatment of disease.
  • Instead of working wholly within the CT system’s narrow bore, interventionalists using CT-Navigation can simply place a sensor on the patient inside the gantry.
  • Today, the innovative solution focuses solely on CT applications, but GE HealthCare plans to expand the technology to its image guided therapy (IGT) business in the near future – further advancing its clinical application and reach.
  • Additionally, GE HealthCare is showcasing CT-Navigation at the European Conference on Interventional Oncology (ECIO) in Stockholm, Sweden.

Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021

Retrieved on: 
Thursday, September 30, 2021

Aileron is pursuing a clinical development strategy designed to advance its vision to bring selective chemoprotection to all patients with

Key Points: 
  • Aileron is pursuing a clinical development strategy designed to advance its vision to bring selective chemoprotection to all patients with
    p53-mutated cancer regardless of type of cancer or chemotherapy.
  • Aileron is a clinical stage chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients.
  • Nearly 1 million patients in the U.S., across all cancer types, are diagnosed annually with p53-mutated cancer.
  • Our vision is to bring selective chemoprotection to patients with p53-mutated cancers regardless of type of cancer or chemotherapy.